OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001873875

Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. (CIK 0001873875, ticker IXHL) reported revenue of $0 for FY2026 (2025-07-01 to 2026-06-30) and net income of -$19.3 million (-$19,302,000) for FY2026 (2025-07-01 to 2026-06-30), as filed in its 10-K filed 2026-09-25 (accession 0001628280-26-063506).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends June 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001873875
TickersIXHL (Nasdaq)
EINnot in EDGAR (or not a valid EIN)
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endJune 30
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
Olympus entity IDorg_61d9shrqpq7d4j4sz5en0sehqf
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20262025-07-01 to 2026-06-3010-K2026-09-250001628280-26-063506RevenueFromContractWithCustomerIncludingAssessedTax
Net income-$19,302,000FY20262025-07-01 to 2026-06-3010-K2026-09-250001628280-26-063506NetIncomeLoss
Total assets$72,979,000FY2026as of 2026-06-3010-K2026-09-250001628280-26-063506Assets
Total liabilities$5,606,000FY2026as of 2026-06-3010-K2026-09-250001628280-26-063506Liabilities
Stockholders' equity$67,373,000FY2026as of 2026-06-3010-K2026-09-250001628280-26-063506StockholdersEquity
Operating cash flow-$12,867,000FY20262025-07-01 to 2026-06-3010-K2026-09-250001628280-26-063506NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$1.66 per shareFY20262025-07-01 to 2026-06-3010-K2026-09-250001628280-26-063506EarningsPerShareDiluted
Shares outstanding12,544,627 sharesFY2026as of 2026-09-2410-K2026-09-250001628280-26-063506EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2017-2026, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20262025-07-01 to 2026-06-30$010-K2026-09-250001628280-26-063506
RevenueFY20252024-07-01 to 2025-06-30$86,00010-K2026-09-250001628280-26-063506
RevenueFY20242023-07-01 to 2024-06-30$12,00010-K2024-09-300001213900-24-082937
Net incomeFY20262025-07-01 to 2026-06-30-$19,302,00010-K2026-09-250001628280-26-063506
Net incomeFY20252024-07-01 to 2025-06-30-$46,885,00010-K2026-09-250001628280-26-063506
Net incomeFY20242023-07-01 to 2024-06-30-$18,459,00010-K2025-09-290001213900-25-092837

Recent 10-K and 10-Q filings

All 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K2026-09-252026-06-300001628280-26-063506ixhl-20260630.htm
10-Q2026-05-152026-03-310001213900-26-057227ea0290776-10q_incannex.htm
10-Q2026-02-132025-12-310001213900-26-015867ea0276323-10q_incannex.htm
10-Q2025-11-142025-09-300001213900-25-110299ea0265260-10q_incannex.htm
10-K2025-09-292025-06-300001213900-25-092837ea0258594-10k_incannex.htm
10-Q2025-05-152025-03-310001213900-25-043682ea0242099-10q_incannex.htm
10-Q2025-02-142024-12-310001213900-25-013783ea0230488-10q_incannex.htm
10-Q2024-11-142024-09-300001213900-24-098421ea0221003-10q_incannex.htm
10-K2024-09-302024-06-300001213900-24-082937ea0212488-10k_incannex.htm
10-Q2024-05-152024-03-310001213900-24-043391ea0206027-10q_incannex.htm
10-Q2024-02-142023-12-310001213900-24-013611f10q1223_incannex.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001873875published by the sourcedata.sec.gov/submissions/CIK0001873875.json2026-10-21

Former names

NameFromTo
Incannex Healthcare Ltd2021-08-172023-11-29

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001873875.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001873875.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001873875" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001873875/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001873875/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1873875"}

On SEC EDGAR

About this data